Video Experimental Relacionado
Updated: Jul 9, 2026
06:05
Visualization and Quantitative Analysis of Embryonic Angiogenesis in Xenopus tropicalis
Published on: May 25, 2017
Exigencia de JNK2 para la formación de células de espuma mediadas por el receptor carroñero A en la aterogénesis
Romeo Ricci1, Grzegorz Sumara, Izabela Sumara
1Cardiovascular Research, Institute of Physiology, and Division of Cardiology, University Hospital Zurich, CH-8057 Zurich, Switzerland. romeo.ricci@cell.biol.ethz.ca
Science (New York, N.Y.)
|November 30, 2004
Resumen
c-Jun Las quinasas N-terminales (JNKs) juegan un papel en la aterosclerosis. La deficiencia de JNK2 en ratones redujo la formación de placa al afectar la absorción de lípidos en los macrófagos, destacando a JNK2 como un objetivo terapéutico potencial para la aterosclerosis.
Área de la Ciencia:
- Biología Cardiovascular Biología Cardiovascular
- La medicina molecular es una medicina molecular.
- Inmunología Inmunología.
Sus antecedentes:
- Los estudios in vitro implican las quinasas c-Jun N-terminales (JNK) en los procesos celulares que contribuyen a la aterosclerosis.
- La aterosclerosis es una enfermedad inflamatoria compleja caracterizada por la acumulación de placa en las arterias.
Objetivo del estudio:
- Investigar los roles específicos de JNK1 y JNK2 en el desarrollo de la aterosclerosis.
- Determinar los mecanismos moleculares por los cuales los JNK regulan la función de los macrófagos en la aterogénesis.
Principales métodos:
- Utilizó ratones con deficiencia de apolipoproteína E (ApoE-/-) que carecían de JNK1 o JNK2.
- Inhibidores farmacológicos de JNK administrados.
- Se examinó la formación de células de espuma de macrófagos y la expresión y fosforilación del receptor carroñero A (SR-A).
- Realizó estudios de eliminación de JNK2 específicos de los macrófagos.
Principales resultados:
- Los ratones ApoE-/- que carecían de JNK2, pero no de JNK1, mostraron una reducción significativa de la aterosclerosis.
- La inhibición farmacológica de JNK disminuyó efectivamente la formación de placa aterosclerótica.
- Los macrófagos deficientes en JNK2 mostraron deterioro en la formación de células espumosas debido a un manejo defectuoso de lipoproteínas modificadas.
- La deficiencia de JNK2 condujo a un aumento de los niveles de receptor carroñero A (SR-A) y disminuyó su fosforilación.
- La deleción de JNK2 específica de los macrófagos fue suficiente para atenuar la aterogénesis.
Conclusiones:
- JNK2, pero no JNK1, juega un papel crítico en la promoción de la aterosclerosis.
- La fosforilación dependiente de JNK2 de SR-A es esencial para la absorción de lípidos por los macrófagos, impulsando la formación de células espumosas.
- Dirigirse a JNK2 ofrece una estrategia terapéutica potencial para reducir la progresión de la aterosclerosis.
Videos de Conceptos Relacionados
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
01:16Cell Motility through Blebbing
Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...
Blebbing Through the Matrix
In multicellular...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24Overview of Cell-Matrix Interactions
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...